SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...
ResMed is a major player in the PAP market. Credit: sbw18 via Shutterstock. ResMed’s Class I recall of its AirFit and AirTouch continuous positive airflow pressure (CPAP) masks threatens the company’s ...
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) has launched ResMed MaskSelector, a digital tool to make remote patient mask selection and sizing easier and more effective, helping patients ...
Sleek product design and engaging smartphone app revolutionizes CPAP experience for the world's 100 million sleep apnea sufferers SAN DIEGO, April 25, 2017 /PRNewswire/ -- ResMed (NYSE: RMD) today ...
ResMed Chief Product Officer Justin Leong and Global Sleep Product Manager Lai Ying Ho discuss the AirFit F40 mask’s design and development. If you search FDA records for ResMed’s new AirFit F40 ...
The AirTouch N20, one of the devices affected by the corrective action. [Image from ResMed] The FDA announced that ResMed’s voluntary recall of millions of CPAP mask magnets is now Class I, the agency ...
SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback